Comparison Of Intermittent and Continuous Dosing Regimens Of Pomalidomide In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Blood
Institution: Yale Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2470833619
